SCHEMBL23930918

SCHEMBL23930918

Cc1ncn(C)c1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.36
GABRA5 P31644 6/20 0.36
GABRG2 P18507 5/20 0.36
GABRB3 P28472 5/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
ALDH1A1 P00352 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
CYP1A2 P05177 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GABRA3 P34903 4/20 0.33
GABRA6 Q16445 4/20 0.33
PIK3CD O00329 1/20 0.33
GABRA2 P47869 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930969 0.81 GABRA1 (0.36) GABRA1GABRA5GABRG2GABRB3APOBEC3A
SCHEMBL27342394 0.79 APOBEC3A (0.38) APOBEC3AAPOBEC3GALDH1A1TP53MAPT
SCHEMBL5937208 0.77 ALDH1A1 (0.47) APOBEC3AAPOBEC3GALDH1A1CYP1A2TP53
SCHEMBL25562761 0.77 APOBEC3A (0.39) APOBEC3AAPOBEC3GALDH1A1TP53MAPT
SCHEMBL24927744 0.76 DYRK1A (0.38) ALDH1A1MAPT
SCHEMBL28811842 0.75 KDR (0.47) GABRA1GABRA5GABRG2GABRB3ALDH1A1
SCHEMBL29779719 0.73 PIK3CD (0.35) GABRA1GABRA5GABRG2GABRB3APOBEC3A
SCHEMBL23716719 0.72 APOBEC3A (0.41) APOBEC3AAPOBEC3GALDH1A1CYP2C19TP53
SCHEMBL21879824 0.72 USP30 (0.45) GABRA5PIK3CD
SCHEMBL29779714 0.71 GABRA1 (0.43) GABRA1GABRA5GABRG2GABRB3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed